PCSK9 and cancer: The decreased expression can be attributed to mutations in PCSK-9 as well as deregulations in cancer signaling pathways (e.g., NF-κβ) that facilitate cholesterol accumulation through decreased PCSK-9 expression (He et al., 2017).